LPL Financial »

Adaptimmune Therapeutics shares owned by LPL Financial

Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by LPL Financial from 13F filings

Historical chart of LPL Financial investment in Adaptimmune Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Adaptimmune Therapeutics held by LPL Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adaptimmune Therapeutics by LPL Financial

Quarter filed Position value Share count Share price at filing
2024-09-30 $84k 89k 0.95
2024-06-30 $194k 199k 0.97
2024-03-31 $172k 109k 1.58